
Glaucoma meds adherence key
The Collaborative Initial Glaucoma Treatment Study (CIGTS) findings show patients who consistently take their glaucoma medication are less likely to develop vision loss. “It is reassuring when

The Collaborative Initial Glaucoma Treatment Study (CIGTS) findings show patients who consistently take their glaucoma medication are less likely to develop vision loss. “It is reassuring when

Tel Aviv University researchers have found a way to incorporate ultra-thin metasurfaces into standard contact lenses, offering a convenient and comfortable way to correct various forms

The amendments to the Health Practitioner Regulation National Law requirements on mandatory notifications are effective since 1 March 2020. “The amendments are designed to support practitioner health

Leading industry bodies have spoken out over controversial plans to begin optometry and DO apprenticeships through large employers in the UK, with Kiwis concerned the plans may land here.

Vision Expo East and LOFT NYC, both scheduled for 26-29 March 2020 in New York City, have been cancelled due to the advancing spread of the covid-19 virus. Vision Expo East will be consolidated with

Researchers from Rochester University in New York have discovered that small eye movements we’re not even aware of, can have a large effect on our visual acuity (VA).

Specsavers has partnered with DKNY, launching sun and optical frames nationwide.

Dr Lisa Hamm of Auckland University has been awarded the Rutherford Foundation post-doctoral fellowship for her research project Learning to see: Identifying visual processing challenges through innovative assessment tools.

New Zealand’s annual ophthalmology conference, the Royal Australia and New Zealand College of Ophthalmologists (RANZCO) New Zealand Branch meeting, due to be held in Christchurch from 8-9 May, has been cancelled.

Nicola Finetti, ODMA Award of Excellence winner and one of Australia’s most respected fashion designers, has unveiled a new eyewear collection.

Phase IIb clinical trials have begun to test the effects of an orally administered small molecule CCR3 inhibitor in wet AMD patients.
Optical lens laboratory, Independent Lens Specialist (ILS) has announced the launch of Shamir’s new extended product range. The official launch of the new extended range cements the companies’ merger,